Printer Friendly

Antibody treatment stifles peanut reactions. (Tough Nut Is Cracked).

Researchers have successfully demonstrated the first preventive treatment against peanut allergy. The drug, which raises the threshold at which allergic people react to peanuts, could reach the market in 2 to 3 years, the scientists say.

In some ways, a peanut allergy is the worst kind, says Hugh A. Sampson of Mount Sinai School of Medicine in New York. Peanuts and peanut oil crop up in unlikely foods, such as egg rolls and chili, and can trigger severe reactions. Roughly 50 to 100 deaths every year in the United States can be traced to peanut allergies, Sampson says. What's more, while many children outgrow allergies to other foods, he says, "most people don't outgrow a peanut allergy."

Sampson and his colleagues enrolled 84 people who had a peanut allergy. The scientists gave the participants, ages 12 to 60, four injections over 4 months. One-fourth received inert shots; the others got various doses of an experimental anti-allergy drug called TNX-901. Neither the researchers nor the volunteers knew which shots were placebos.

Two to 4 weeks after the last injection, the volunteers were brought into a clinic and, at 40-minute intervals, given capsules containing peanut flour. Each person received increasing doses of the flour until researchers diagnosed an allergic reaction

The test showed that volunteers getting a placebo could withstand the equivalent of only half a peanut before reacting. People who received light doses of TNX-901 could handle slightly more. Study participants getting the highest doses of the drug withstood, on average, the equivalent of about nine peanuts before having a reaction, says study coauthor Donald Y.M. Leung of the National Jewish Medical and Research Center in Denver. Some managed the equivalent of 24 peanuts, he says. He and Sampson estimate that the average accidental exposure to peanuts is equal to one to two peanuts.

The study appears in the March 13 New England Journal of Medicine.

Allergic reactions occur when immune cells respond to a harmless substance by making a rogue version of an otherwise useful type of antibody called immunoglobulin E (IgE). When this wayward antibody binds to so-called mast cells in the skin, the lung, and mucus membranes, those cells produce rash-causing histamines and spur an influx of inflammatory proteins that causes swelling. Such an allergic reaction can bring on anaphylactic shock.

TNX-901 is a genetically engineered anti-body that latches onto the rogue IgE anti-body and prevents them from binding to mast cells, Leung says. In the study, people getting TNX-901 showed a significant drop in IgE antibodies in their blood.

Noting that the study applies earlier research on hay fever and asthma to the realm of food allergies, Henry Metzger of the National Institute of Arthritis and Musculoskeletal and Skin Diseases in Bethesda, Md., calls the work an example of "beautiful translational research."

In the same journal issue carrying these findings, researchers in Britain report that baby lotion containing peanut oil may cause peanut allergy in some children (see
COPYRIGHT 2003 Science Service, Inc.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2003, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

Article Details
Printer friendly Cite/link Email Feedback
Author:Seppa, N.
Publication:Science News
Geographic Code:1USA
Date:Mar 15, 2003
Previous Article:Les bon temps rouler. (Letters).
Next Article:Shuttle-borne radar detects remnant of dino-killing impact. (Killer Crater).

Related Articles
Food allergy: analyzing fatal reactions.
Family allergies? Keep nuts away from baby.
Allergies attack!
Nut Allergies.
A rash of kisses: in some people with food allergies, a smooch can trigger hives and more.
Allergies & women's health.
Should schools ban peanut butter? (Debate).
Treatment and prevention of food allergies in breastfed infants: practice and evidence.
Why apple allergen survives processing.

Terms of use | Privacy policy | Copyright © 2020 Farlex, Inc. | Feedback | For webmasters